When Tony Wood became GSK’s top scientist in mid-2022, the British pharma was waging battle.
GSK was fighting Zantac-related litigation in court while struggling to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate
Patients on antipsychotics need to be regularly monitored for signs of tardive dyskinesia, a medication-induced movement disorder diagnosed when the involuntary movements persist for at
Roche’s Genentech unit will cut 3% of workers, a spokesperson told Endpoints News Wednesday, making it the latest drugmaker to announce staffing reductions in recent